WMCC

/WMCC

About WMCC

This author has not yet filled in any details.
So far WMCC has created 44 blog entries.

Breast

A011106: Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study A011502: A Randomized Phase III Double Blinded Placebo-Controlled Trial of Aspirin as Adjuvant Therapy for Node-Positive, HER2 Negative Breast Cancer: The Aspirin for Breast Cancer Study (ABC Study) A171601: A Phase II Trial [...]

Breast2019-03-18T09:29:18-04:00

Genitourinary System

A031102: A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors – MALE GENDER ONLY. NRG GU006: Phase II, Double Blinded, Placebo Controlled Randomized Trial of [...]

Genitourinary System2019-03-15T10:02:22-04:00

Symptom Management and Cancer Control Protocols

Alliance A221101: A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil) to Reduce Cancer-Related Fatigue in Patients with High Grade Glioma. EA1151: Tomosynthesis Mammographic Imaging Screening Trial (TMIST) EAQ162CD: Longitudinal Assessment of Financial Burden in Patients with Colon or Rectal Cancer Treated with Curative Intent PCYC-1134M: informCLL: A Disease Registry for Patients with Chronic Lymphocytic Leukemia S0820: [...]

Symptom Management and Cancer Control Protocols2019-03-15T09:42:38-04:00

Gynecologic

EAY131 (MATCH): Molecular Analysis for Therapy Choice GOG 0238: A randomized trial of pelvic irradiation with or without concurrent weekly cisplatin in patients with pelvic-only recurrence of carcinoma of the uterine corpus GOG 0263: Randomized phase III clinical trial of adjuvant radiation vs. chemoradiation in intermediate risk, stage I/IIA cervical cancer treated with initial radical hysterectomy [...]

Gynecologic2019-02-13T15:36:48-04:00

Gastrointestinal System

A021501: Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas A021502: Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair. (ATOMIC: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer) EA2142: Randomized [...]

Gastrointestinal System2019-02-13T15:36:48-04:00

Medical Oncology & Infusion Services Transitioning to Partner Hospitals

You may have recently heard news regarding changes planned for West Michigan Cancer Center & Institute for Blood Disorders (WMCC).  With this article, we hope to clarify the news and explain what patients and caregivers can anticipate moving forward. Our partner hospitals—Borgess and Bronson—have created a plan to strengthen the delivery of cancer care in [...]

Medical Oncology & Infusion Services Transitioning to Partner Hospitals2019-02-13T15:36:48-04:00

Head & Neck

EA3132: Phase II Randomized Trial of Adjuvant Radiotherapy with or without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) RTOG 1008: A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors    

Head & Neck2019-02-13T15:36:48-04:00

Sarcomas

No Clinical Trials Available

Sarcomas2019-02-13T15:36:48-04:00

Myeloma

A061402: Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment with Adjuvant Systemic Treatment and Zoledronic Acid Versus Zoledronic Acid after Definite Radiation Therapy E1A11: Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic [...]

Myeloma2019-02-13T15:36:48-04:00

Lymphoma

BMTCTN 1101: A Multi-Center, Phase III, Randomized Trial of Reduced Intensity (RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) vs HLA-Haploidentical Related Bone Marrow for Patients with Hematologic Malignancies (Spectrum Health Adult Bone Marrow Transplant Program) Dana Farber: 14-174: Study of Precursor Hematological Malignancies to Assess the Relationship Between Molecular Events of Progression and [...]

Lymphoma2019-02-13T15:36:48-04:00